Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients
Objectives Atrial fibrillation (AF) is the most common persistent arrhythmia and has adverse outcomes in hemodialysis patients. It is obscure the relationship between BNP and AF in hemodialysis patients. This study investigated the interventionable predictors of AF in hemodialysis patients.Methods I...
Saved in:
| Main Authors: | Ling Yu, Jia Huang, Yanchun Li, Han Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2463563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01) -
Pericardial Fluid Biomarkers as Early Predictors for Postoperative Atrial Fibrillation—A Systematic Review
by: Florin Mitu, et al.
Published: (2025-02-01) -
N-terminal brain natriuretic peptide used for evaluation of dry weight in patients undergoing maintenance hemodialysis
by: TANG Xiao-fang, et al.
Published: (2016-01-01) -
Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
by: Zakaria Almuwaqqat, et al.
Published: (2019-10-01) -
Possibilities of Using Blood Natriuretic Peptide Levels as Biomarkers of Morbidity and Aging
by: Dzeranova, N.Y., et al.
Published: (2024-12-01)